The FDA will soon decide on Merck's COVID-19 pill. Here are

A team of infectious disease advisers will soon look at the results of Merck's clinical trial and decide whether to recommend emergency use authorization for the first pill to treat early-stage COVID-19.

Related Keywords

Alabama , United States , United Kingdom , Todd Sherer , Brandon Malone , Daria Hazuda , Mark Denison , Elizabeth Campbell , Rustem Ismagilov , Davidson Goldin , Peter Hotez , Eric Rubin , Wendy Holman , Ridgeback Biotherapeutics , Emory Office Of Technology , Vanderbilt University Medical Center , Rockefeller University Lethal , National Institute Of Allergy , Drug Administration , Advisory Committee , Cnn , Antimicrobial Drugs Advisory Committee , Pfizer , California Institute Of Technology , Emory University In Atlanta , Baylor College Of Medicine , Defense Threat Reduction Agency , George Painter , Emory University , Vanderbilt University Medical , Middle East Respiratory Syndrome , Public Health , New England Journal , Baylor College , Rockefeller University , Nature Structural , Molecular Biology , Cal Tech , California Institute , Drugs Advisory Committee , National Institute , Infectious Diseases , Emory In January , Drug Innovation Ventures , Jbnd , Merck , Coronavirus , Covid 19 , Hill , Fda , Review , Experts , Medication , Research ,